1. Home
  2. PCRX vs ALEX Comparison

PCRX vs ALEX Comparison

Compare PCRX & ALEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • ALEX
  • Stock Information
  • Founded
  • PCRX 2006
  • ALEX 1870
  • Country
  • PCRX United States
  • ALEX United States
  • Employees
  • PCRX N/A
  • ALEX N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • ALEX Real Estate Investment Trusts
  • Sector
  • PCRX Health Care
  • ALEX Real Estate
  • Exchange
  • PCRX Nasdaq
  • ALEX Nasdaq
  • Market Cap
  • PCRX 1.2B
  • ALEX 1.3B
  • IPO Year
  • PCRX 2011
  • ALEX N/A
  • Fundamental
  • Price
  • PCRX $22.76
  • ALEX $16.57
  • Analyst Decision
  • PCRX Buy
  • ALEX Buy
  • Analyst Count
  • PCRX 5
  • ALEX 2
  • Target Price
  • PCRX $32.40
  • ALEX $24.00
  • AVG Volume (30 Days)
  • PCRX 479.4K
  • ALEX 437.3K
  • Earning Date
  • PCRX 11-05-2025
  • ALEX 10-30-2025
  • Dividend Yield
  • PCRX N/A
  • ALEX 5.42%
  • EPS Growth
  • PCRX N/A
  • ALEX 94.65
  • EPS
  • PCRX N/A
  • ALEX 1.07
  • Revenue
  • PCRX $705,848,000.00
  • ALEX $238,308,000.00
  • Revenue This Year
  • PCRX $7.36
  • ALEX N/A
  • Revenue Next Year
  • PCRX $10.07
  • ALEX $1.78
  • P/E Ratio
  • PCRX N/A
  • ALEX $15.49
  • Revenue Growth
  • PCRX 2.25
  • ALEX 8.21
  • 52 Week Low
  • PCRX $16.00
  • ALEX $15.70
  • 52 Week High
  • PCRX $27.64
  • ALEX $19.97
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 35.28
  • ALEX 26.86
  • Support Level
  • PCRX $24.31
  • ALEX $16.48
  • Resistance Level
  • PCRX $26.05
  • ALEX $16.96
  • Average True Range (ATR)
  • PCRX 0.82
  • ALEX 0.28
  • MACD
  • PCRX -0.20
  • ALEX -0.10
  • Stochastic Oscillator
  • PCRX 18.36
  • ALEX 5.08

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About ALEX Alexander & Baldwin Inc. REIT Holding Company

Alexander & Baldwin Inc is a Hawaii commercial real estate company. The group owns, operates, and manages million square feet of retail, industrial, and office space in Hawaii. It is a real estate investment trust (REIT) and the owner of grocery and drug-anchored retail centers in the state. It functions through two segments namely Commercial Real Estate and Land Operations. The Commercial Real Estate segment owns and manages retail, industrial spaces, and also urban ground leases in Hawaii, thereby accounting for a majority of the company's revenue. The Land Operations segment actively manages the company's land and real estate-related assets and makes optimum utilization of these assets. Geographically, the activities are carried out across the United States.

Share on Social Networks: